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ABSTRACT Epidemics of invasive meningococcal disease (IMD) caused by menin-
gococcal serogroup A have been eliminated from the sub-Saharan African so-called
“meningitis belt” by the meningococcal A conjugate vaccine (MACV), and yet, other
serogroups continue to cause epidemics. Neisseria meningitidis serogroup W remains
a major cause of disease in the region, with most isolates belonging to clonal com-
plex 11 (CC11). Here, the genetic variation within and between epidemic-associated
strains was assessed by sequencing the genomes of 92 N. meningitidis serogroup W
isolates collected between 1994 and 2012 from both sporadic and epidemic IMD
cases, 85 being from selected meningitis belt countries. The sequenced isolates be-
longed to either CC175 (n  9) or CC11 (n  83). The CC11 N. meningitidis sero-
group W isolates belonged to a single lineage comprising four major phylogenetic
subclades. Separate CC11 N. meningitidis serogroup W subclades were associated
with the 2002 and 2012 Burkina Faso epidemics. The subclade associated with the
2012 epidemic included isolates found in Burkina Faso and Mali during 2011 and
2012, which descended from a strain very similar to the Hajj (Islamic pilgrimage to
Mecca)-related Saudi Arabian outbreak strain from 2000. The phylogeny of isolates
from 2012 reflected their geographic origin within Burkina Faso, with isolates from
the Malian border region being closely related to the isolates from Mali. Evidence of
ongoing evolution, international transmission, and strain replacement stresses the
importance of maintaining N. meningitidis surveillance in Africa following the MACV
implementation.
IMPORTANCE Meningococcal disease (meningitis and bloodstream infections)
threatens millions of people across the meningitis belt of sub-Saharan Africa. A vac-
cine introduced in 2010 protects against Africa’s then-most common cause of me-
ningococcal disease, N. meningitidis serogroup A. However, other serogroups con-
tinue to cause epidemics in the region—including serogroup W. The rapid
identification of strains that have been associated with prior outbreaks can improve
the assessment of outbreak risk and enable timely preparation of public health re-
sponses, including vaccination. Phylogenetic analysis of newly sequenced serogroup
W strains isolated from 1994 to 2012 identified two groups of strains linked to large
epidemics in Burkina Faso, one being descended from a strain that caused an out-
break during the Hajj pilgrimage in 2000. We find that applying whole-genome se-
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quencing to meningococcal disease surveillance collections improves the discrimina-
tion among strains, even within a single nation-wide epidemic, which can be used
to better understand pathogen spread.
KEYWORDS: Africa, Neisseria meningitidis, disease outbreaks, epidemiology,
evolution, meningitis, meningococcus
The pathogen Neisseria meningitidis is a common cause of meningitis in the 26sub-Saharan Africa countries of the so-called “meningitis belt,” where small annual
epidemics and periodic large epidemics contribute to the highest incidence of menin-
gococcal meningitis in the world (1). N. meningitidis serogroup A disease has dramat-
ically decreased since the initiation of mass vaccination with the meningococcal A
conjugate vaccine (MACV) in 2010 (2, 3), and yet, affordable conjugate vaccines are not
available for other serogroups that have caused epidemics in Africa. N. meningitidis
serogroup W remains a major cause of meningococcal disease in the region (4).
The first large outbreak of N. meningitidis serogroup W disease occurred during the
2000 Hajj to Saudi Arabia (Islamic pilgrimage to Mecca), with over 300 cases reported
worldwide (5, 6). N. meningitidis serogroup W isolates from this outbreak (hereinafter,
the Hajj-related outbreak strain) belonged to clonal complex 11 (CC11), a hyperinvasive
lineage typically identified with N. meningitidis serogroup C disease (7, 8). All known
CC11 N. meningitidis serogroup W isolates originate from a single ancestral strain, with
some isolates having been collected as early as 1970 (8, 9). CC11 N. meningitidis
serogroup W isolates have become globally distributed and were reported in menin-
gitis belt countries as early as 1993 (9) but were not reported from epidemics until 2001
(10). Although N. meningitidis serogroup W disease caused by both CC11 and CC175
has been reported in meningitis belt countries (11), only N. meningitidis serogroup W
CC11 has caused epidemics. A large N. meningitidis serogroup W epidemic occurred in
Burkina Faso during 2002, with 12,587 cases reported (12, 13). Since then, additional N.
meningitidis serogroup W epidemics have only occurred since 2010 (14, 15), including
the CC11 epidemic in Burkina Faso during 2012, with 5,807 cases reported (4, 16, 17).
The occurrence of several CC11 N. meningitidis serogroup W epidemics since 2000
raised concerns that the Hajj-related outbreak strain had become established in the
meningitis belt after being carried there by returning pilgrims (12, 14, 18). This was of
particular concern because the attack rate among returning pilgrims was reported to be
as high as 25 per 100,000 population, with a case fatality rate as high as 37% (19),
suggesting that the Hajj-related outbreak strain may have been more virulent than
other N. meningitidis serogroup W strains. Isolates that evolved from this strain continue
to be identified around the world, and these strains may have become endemic in
regions as distant as South Africa, Turkey, and Europe (8, 20). However, CC11 N.
meningitidis serogroup W strains that are endemic to the United Kingdom and Chile did
not evolve from the Hajj-related outbreak strain (8, 20). While isolates from the 2002
epidemic in Burkina Faso did not evolve from the Hajj-related outbreak strain (12, 20,
21), they are closely related, and it is unclear when these two strains diverged or
whether the recent CC11 N. meningitidis serogroup W isolates from meningitis belt
countries are descended from the Hajj-related outbreak strain.
Here, we applied whole-genome sequencing to analyze the evolution of N. menin-
gitidis serogroup W populations in the meningitis belt countries from 1994 to 2012.
Isolates collected during the 2012 epidemic in Burkina Faso and the preceding years in
the belt were analyzed to identify the origin of the 2012 epidemic N. meningitidis
serogroup W and the relationship of that epidemic to the 2002 epidemic in Burkina
Faso. Isolates collected during the Hajj-related Saudi Arabian outbreak in 2000 and
during the following years in Africa were analyzed to evaluate whether the Hajj-related
outbreak strain was dispersed to Africa and contributed to later epidemics. We further
examined the genetic variation among major lineages to identify loci distinguishing the
epidemic-associated isolates from other CC11 N. meningitidis serogroup W strains.
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RESULTS
Overview of phylogenetic diversity. We sequenced the genomes of 92 N. meningitidis
serogroup W isolates, 9 from CC175 and 83 from CC11 (Table 1; see also Table S1 in the
supplemental material). The CC175 genomes had minimal diversity among them and
did not show a clear phylogenetic structure (see Materials and Methods; see also
Fig. S1). Within CC11, we identified four major subclades (I through IV) based on their
association with large epidemics (Fig. 1; Table 2). Subclades I and III did not contain
isolates associated with meningitis epidemics. Subclade I consisted of 7 genomes, with
the only 2 meningitis belt isolates being from the 1990s. Subclade III consisted of 4
isolates from the meningitis belt from 2001 to 2004. One strain (M07161) isolated in
1994 from Mali did not fit into a major subclade but was basal to subclades III and IV
with high bootstrap support (99%).
Sequence diversity was described further by the number of high-quality single-
nucleotide polymorphisms (hqSNPs) between each pair of CC11 isolates in our study
(see Table S2 in the supplemental material). After excluding the outgroup, the align-
ment contained 6,162 variable positions. The diversity within and between each labeled
subclade is given in Table 3 (see also Tables S3 and S4).
Subclade associated with the epidemic in Burkina Faso during 2002.
Subclade II consists of 2 isolates from the first large N. meningitidis serogroup W
epidemic in Burkina Faso (2002), 4 isolates from the previous year, and a later isolate
from Mali (2007). The epidemic-associated isolates had 21 hqSNPs separating them,
greater than the separation between those two and many isolates from 2001, which is
as low as 5 hqSNPs (see Table S5 in the supplemental material). This was in agreement
with the phylogenetic analysis that depicted these 6 isolates as a closely related group
TABLE 1 Epidemiological context for the isolates analyzed in this study
Country ST/CCa Yr collectedb No. of isolates
Algeria ST11/CC11 1997 1
1999 1
2001 1
Benin ST2881/CC175 2004 1
2006 1
2007 1








Cameroon ST11/CC11 2001 2
Central African Republic ST11/CC11 2001 2
Djibouti ST11/CC11 2004 1
Gambia ST11/CC11 1995 1




Mauritius ST11/CC11 2001 1





Saudi Arabia ST11/CC11 2000 1
Senegal ST11/CC11 2002 1
Togo ST2881/CC175 2007 1
Incomplete data ST11/CC11 N/A 2
Previously published ST11/CC11 N/A 4
aST/CC, sequence type profile/clonal complex identifier, from MLST.
bBoldface indicates years with epidemics and large outbreaks involving CC11.
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(Fig. 1) that was clearly distinguishable from the isolate recovered in 2004 (subclade III)
and the later isolate from Mali in 2007 (subclade II).
Subclade II was distinguished from the others by 128 hqSNPs found in 16 diverse
locations in the genome (see Table S4 in the supplemental material). A large cluster of
hqSNPs was present in proximity to the nadC, nicA, and nicB genes (PubMLST identifiers
[IDs] NEIS1770 to NEIS1773; 96 hqSNPs).
Subclade associated with the outbreak in Saudi Arabia during 2000. Sub-
clade IV (n  67) was defined by two isolates from the Hajj-related Saudi Arabian
outbreak in 2000 (M07149 and M7124), plus 8 isolates collected from varied locations
in Africa between 2001 and 2004. A group of 6 genomes had a maximum of 18 hqSNP
differences from each other, each substitution being unique to a single genome
(M22722, M22740, M22747, M7124, M07149, and M12752). M07149 had no unique
substitutions, indicating that it was very similar to the most recent common ancestor
of subclade IV (see Tables S1 and S2 in the supplemental material).
Subclade IV had 24 hqSNPs that distinguished it from other clades (see Table S3 in
the supplemental material). These were distributed in 19 genome locations, with small
clusters in proximity to the genes greA (NEIS1365; 2 hqSNPs) and lgtA (NEIS1902; 4
hqSNPs). Inclusion of the SNPs from the Mauve alignment also identified pglB
(NEIS0399). The clade including subclades III and IV had 91 discriminatory hqSNPs,
including one cluster near the argH and galU genes (NEIS0580 and NEIS0581; 46
hqSNPs), and another near the nor and aniA genes (NEIS1548; aniA is not in PubMLST;
26 hqSNPs). There were no polymorphisms shared among the epidemic subclades (II
and IV) that distinguished them from the remainder of the collection.
Subclade associated with the epidemic in Burkina Faso during 2012. A
nested clade within subclade IV, defined as subclade IVa, comprised 55 isolates from
Mali and Burkina Faso in 2011 and 2012 (Fig. 2). Burkina Faso experienced a widespread
epidemic in 2012, and all 21 isolates from that year were in subclade IVa. These isolates








M08000: Burkina Faso 2001
M22745: Burkina Faso 2001
M08001: Burkina Faso 2001
M07999: Burkina Faso 2001
M09293: Burkina Faso 2002 [epidemic]
M09261: Burkina Faso 2002 [epidemic]
M22191: Mali 2007
M07161: Mali 1994
M22748: Central African Republic 2001
M22769: Niger 2002
M22759: Niger 2001
M22797: Burkina Faso 2004
M22772: Senegal 2002
M7124: Saudi  Arabia 2000 [epidemic]










FIG 1 Maximum-likelihood phylogeny of 86 CC11 N. meningitidis serogroup W isolates, rooted on NM3683. Branches with less than 85% bootstrap
support are collapsed. Scale bar represents one substitution per 10,000 bases in the whole-genome alignment. Isolates are labeled with country and year
of isolation if available. Isolates from the 2002 Burkina Faso epidemic and the 2000 Hajj-related Saudi Arabian outbreak are in boldface. Clades are labeled
at their roots and described in the text. Subclade IVa is presented in Fig. 2.
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isolates (see Materials and Methods). Phylogeographic structure within Burkina Faso
was evident in some of the clades, but there was also evidence of repeated transmis-
sion between countries. For instance, the 7 isolates from Centre Hospitalier Universi-
taire Sanou Souro (CHU-SS) form a monophyletic group (Fig. 2, subclade IVa1). Of the
22 isolates from Mali, 9 were in subclade IVa2 and 7 in subclade IVa3. The only other
isolates in those subclades were from Centre Muraz, which covers districts bordering
Mali; of the 6 isolates from Centre Muraz, 3 were in IVa2 and 1 in IVa3. In contrast, the
isolates from Centre Hospitalier Universitaire Pédiatrique-Charles de Gaulle (CHUP-CDG)
in 2012 were widely dispersed (including the most divergent isolates, M25434 and
M25433), consistent with this laboratory receiving isolates from varied locations in
Burkina Faso.
Isolates from the 2012 Burkina Faso epidemic had a maximum of 684 hqSNPs
between any two isolates (see Table S6 in the supplemental material), accounting for
the broad diversity of subclade IVa. Some of these isolates were very similar to isolates
collected in Burkina Faso during 2011 (6 hqSNPs) and in Mali during 2012 (1 hqSNP),
consistent with the phylogeny, where none of these groups were monophyletic.
Subclade IVa was distinguished from other subclades by 240 hqSNPs found in 17
locations on the genome (see Table S4).
TABLE 2 Observations of isolates from clonal complex 11 subcladesa
Region and country
No. of isolates from indicated subclade inc:
1994 1995 1997 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2010 2011 2012
Hyperendemic
meningitis belt






Niger 1 III 1 III * * *
Nonhyperendemic
meningitis belt










Algeria 1 I 1 I 1 IV
Djibouti 1 IV
Mauritius 1 IV
Saudi Arabia 1 IV
aSubclades are identified in Fig. 1 and text.
bNA, not applicable; isolate M07161 did not fit into a major subclade.
cAsterisk indicates single observation of CC175 isolate.
TABLE 3 Core genome similarity between isolates in the major subclades
Subclade
Range of hqSNP counts or % similarity between indicated subcladesa
I II III IV IVa
I 26–1,410 99.97 99.96 99.97 99.95
II 642–1,488 2–238 99.98 99.98 99.97
III 707–1,467 393–697 20–310 99.99 99.98
IV 662–1,904 348–1137 132–897 0–1,221 100
IVa 938–1,904 637–1,137 417–897 0–1,221 0–684
aMinimum and maximum counts of hqSNPs distinguishing isolates in the subclades are presented on the
diagonal and below. Maximum sequence similarity between isolates, based on an alignment of 1,982,813
nucleotides, is presented above the diagonal in boldface. Isolate counts for each subclade are I (n  7), II
(n  7), III (n  4), IV (n  67), and IVa (n  55).
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Diversity at possible subtyping loci. We examined the diversity in several genes
that are regularly used to genotype meningococcus (see Table S1 in the supplemental
material) (22). The porA subtype was uniform within clonal complexes (P1.5,2 in CC11
and P1.5-1,2-36 in CC175), while the fetA variable region was largely uniform, with a few
low-frequency variants. Sequence variation at the fHbp locus has been proposed as a
potential marker for the Hajj-related outbreak strain (20); we observed 11 fHbp alleles
among the CC11 isolates, encoding six subfamily A proteins and five subfamily B
proteins (alternatively known as variant groups 2/3 or group 1, respectively). Alleles
associated with both subfamilies were found among isolates of subclades I, II, and IVa
(Fig. 3).
To identify additional loci that may distinguish the CC11 subclades from each other,
we evaluated the PubMLST allele assignments at several loci where hqSNPs distinguish
the subclades. A subset of loci for which alleles were strongly associated with subclades
is presented in Table 4 (the full set is in Table S4 in the supplemental material); it
includes two loci from the ribosomal multilocus sequence type (MLST) scheme. Re-
flecting this variation, the subclade IV isolates have ribosomal sequence type (rST) 2332
and subclade IVa isolates have rST 7546 (23).
DISCUSSION
Concern about the epidemic potential of CC11 N. meningitidis serogroup W increased
greatly following the multinational outbreaks among Hajj pilgrims returning from Saudi
Arabia in 2000 (5, 6, 9, 12, 19). The isolates collected from meningitis belt countries in
2001 and 2002 include representatives of three different CC11 N. meningitidis sero-
group W subclades, one of which (subclade IV) may be descended from the strain that
M22160: Mali 2007
M22189: Mali 2007
M24723: Burkina Faso (CHUP-CDG) 2011
M24724: Burkina Faso (CHUP-CDG) 2011
M27559: Burkina Faso (CHU-YO) 2011
M23426: Burkina Faso 2011
M24734: Burkina Faso (CHUP-CDG) 2011
M23414: Burkina Faso 2011
M25432: Burkina Faso (CHUP-CDG) 2012
M23415: Burkina Faso 2011
M25435: Burkina Faso (CHUP-CDG) 2012
M25440: Burkina Faso (CHUP-CDG) 2012
M24731: Burkina Faso (CHUP-CDG) 2011
M23413: Burkina Faso 2011
M23423: Burkina Faso 2011
M25433: Burkina Faso (CHUP-CDG) 2012
M25438: Burkina Faso (CHUP-CDG) 2012
M25466: Burkina Faso (CHU-SS) 2012
M25456: Burkina Faso (CHU-SS) 2012
M25459: Burkina Faso (CHU-SS) 2012
M25462: Burkina Faso (CHU-SS) 2012
M25467: Burkina Faso (CHU-SS) 2012
M25468: Burkina Faso (CHU-SS) 2012
M25469: Burkina Faso (CHU-SS) 2012
M25436: Burkina Faso (CHUP-CDG) 2012




M25430: Burkina Faso (CHUP-CDG) 2012











M25471: Burkina Faso (Centre Muraz)  2012










M25434: Burkina Faso (CHUP-CDG) 2012
M25072: Mali 2012
M25081: Mali 2012
M23422: Burkina Faso 2011
M24730: Burkina Faso (CHUP-CDG) 2011
FIG 2 Maximum-likelihood phylogeny of 55 isolates in subclade IVa, rooted on subclade IV. Branches with less than 70% bootstrap support are collapsed.
Scale bar represents one substitution per 10,000 bases in the whole-genome alignment. Isolates are labeled with country and year of isolation, with
Burkina Faso National Reference Laboratories that provided isolates listed in parentheses. Isolates from Burkina Faso 2012 are in boldface. Subclades
mentioned in the text are labeled at their roots.
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caused the Saudi Arabian outbreak (Table 2). Isolates obtained from the Burkina Faso
2002 epidemic are a separate lineage (subclade II), as are some of the isolates from
disease cases outside large epidemics (subclade III). Four isolates from subclades II and
III were also sequenced for the study of Lucidarme et al. (8) (M22797/30098, M22759/
30087, M22769/30089, and M22745/30104), where they were placed into two clusters
labeled as the “Burkina Faso/North African strains.”
While subclade IV was not the only cause of CC11 N. meningitidis serogroup W
disease in the meningitis belt after 2000, isolates very similar to the Hajj-related
outbreak strain were collected in the region. These strains may have been dispersed
FIG 3 Frequencies of fHbp alleles in each subclade of CC11. Each bar represents a different subclade, colored by the
proportion of isolates from that subclade that carry each allele, with the number of isolates written to the left. The bar
for subclade IV does not include isolates from subclade IVa. Each allele encodes a different protein, and protein
subvariants are listed in the legend.
TABLE 4 Select loci with SNPs distinguishing subclades, described by their PubMLST
allele assignment
Locusa PubMLST IDb Patternc
Allele in subcladed
No. of
SNPsfI II III IVe IVa
mafS7 NEIS2090 II 1 18 1 1g 1 56
nadC NEIS1770 II 1 237 1 1 1 30
nor NEIS1548 III/IVh 149 149 1 1 1 59
galU NEIS0581 III/IVh 230 230 351 351 351i 36
nhbA NEIS2109 III/IVh 17 17 72 72 72 1
opcB NEIS1877 II/III/IV 1 2 2 2j 2 2
folP NEIS1609 II/III/IV 14k 1 1 1 1 67
lgtA NEIS1902 IV 17l 17 17 37l 37 2
lgtB NEIS1901 IV 79 79 79 77m 77 4
rpmA NEIS1848 IV 1 1 1 4 4 1
rpsO NEIS0552 IVa 1 1 1 1 16 1
aLocus names are taken from PubMLST annotation if available; otherwise, the mapping of Fam18
annotations to the reference sequence is used.
bID, identifier.
cSNP patterns are categorized by which subclades are distinguished from the outgroup.
dThe predominant allele is reported for each subclade; minor alleles are noted in the footnotes.
eCounts for subclade IV do not include isolates from subclade IVa.
fThe SNP count is the number of polymorphisms separating the two listed PubMLST alleles.
gmafS7 is not present in M22765.
hM07161 shares alleles with subclades I/II for nor and galU but with III/IV for nhbA.
iM25432 has galU allele 2.
jM22160 and M22189 have opcB allele 47.
kM25419 and M10208 have folP allele 4.
llgtA is not found in M22772 and Nm3686.
mM22772 has lgtB allele 67.
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during the 2000 outbreak, as indicated by the minimal diversity among the subclade IV
isolates collected in 7 countries from 2000 to 2004, the absence of phylogenetic
structure at the base of subclade IV where 9 branches join (Fig. 1), and the absence of
any hqSNPs between the consensus genome sequences of those isolates and the
genome of isolate M07149, which was collected during the Saudi Arabian outbreak.
Two of these isolates were identified as part of the “Anglo-French Hajj strain” by
Lucidarme et al. (8) (M22722/2001076 and M22765/2002029).
The isolates of subclade III were very closely related to the Hajj-related outbreak
strain (99.99% sequence identity; minimum of 132 hqSNPs) and share the antigen gene
profile of the Hajj-related outbreak strain that was identified by Mustapha et al.,
specifically the presence of fHbp allele 9 (Fig. 3) (20). However, they are distinguished
from the Hajj-related outbreak strain at 19 loci where all subclade IV isolates have
derived variants (see Table S4 in the supplemental material), indicating that subclade
III isolates are not derived from the Hajj-related outbreak strain. They are further
distinguished from the subclade IV strains by their greater sequence diversity and the
presence of phylogenetic structure within the clade (Fig. 1), which is evident even when
recombination is accounted for (see Fig. S2). Altogether, this indicates that subclade III
did not undergo the same population dynamics as the strains that make up subclade
IV and is a separate linage.
Isolates from the Burkina Faso epidemic of 2002 comprised a distinct subclade (II),
which clearly diverged from subclades III and IV prior to the 2000 Saudi Arabian
outbreak. This was demonstrated by the presence of an isolate from 1994 (M07161)
being placed on the lineage leading to subclades III and IV with high confidence
(bootstrap value of 99%). In the years after the 2002 epidemic, CC11 N. meningitidis
serogroup W was rarely identified among either disease isolates or carriage isolates (11,
24, 25) until isolates from subclade IVa were recovered in 2011 and 2012. This is
consistent with the “clonal wave” model of meningococcal strain replacement in
meningitis belt countries and communities (26).
Isolates recovered during the 2012 epidemic in Burkina Faso belonged to subclade
IVa, a lineage resulting from the clonal expansion and international dispersion of
subclade IV that coincided with the Hajj-related Saudi Arabian outbreak in 2000. This
subclade contains a different ribosomal MLST profile (7546) than any isolates examined
by Lucidarme et al. (8). The geographic location of the subclade IVa ancestral lineage
between 2000 and 2011 cannot be inferred from the isolate collection in this analysis,
which primarily includes western meningitis belt countries in which a previous study
identified low frequencies of CC11 N. meningitidis serogroup W isolates from 2005 to
2010 (11). One possibility is that this lineage was only introduced to the western
meningitis belt shortly before 2011; alternatively, a local population may not be
represented in this analysis. The phylogeographic structure within subclade IVa indi-
cated that most transmission is geographically restricted during epidemics, but re-
peated pathogen transmission has still occurred across the border of Mali and Burkina
Faso, as indicated by the phylogenetic mixing of isolates from Mali in 2012 with those
collected in Burkina Faso in 2011 and 2012 (Fig. 2). Additional isolates from this clade
were collected in Niger during 2015 (27), demonstrating that CC11 N. meningitidis
serogroup W populations are established in the meningitis belt.
Conclusion. The N. meningitidis serogroup W isolates associated with the epidem-
ics in Burkina Faso during 2002 and 2012 belong to two distinct subclades, closely
related to CC11 isolates recovered from sporadic invasive meningococcal disease cases
in meningitis belt countries since 2000. The subclade associated with the Burkina Faso
epidemic of 2012 was descended from the Hajj-related outbreak strain, which became
globally dispersed near the time of the Hajj-related Saudi Arabian outbreak in 2000.
This subclade included all N. meningitidis serogroup W isolates examined that were
collected from Mali and Burkina Faso in 2011 and 2012, but it included none of the
isolates from the previous decade. These results, along with a large epidemic in Niger
during 2015 caused primarily by a N. meningitidis serogroup C strain first identified in
Retchless et al.
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2013 (27), indicate that meningococci can spread rapidly to cause large epidemics,
stressing the importance of maintaining N. meningitidis surveillance throughout men-
ingitis belt countries following the MACV implementation. The application of whole-
genome sequencing to a greater proportion of representative disease and carriage
isolates will allow high-resolution tracking of pathogen dissemination at the scale of
both countries and continents, detecting epidemic-associated strains as they become
established in new districts and generating hypotheses regarding paths of transmis-
sion.
MATERIALS AND METHODS
Strain selection. A total of 92 isolates from the Centers for Disease Control and Prevention (CDC) culture
collection were sequenced for this analysis; 85 originated from the meningitis surveillance systems of 10
meningitis belt countries (Table 1). Another 7 CC11 isolates from other regions were sequenced, and 4
previously published genomes included, to provide a global context for the diversity of meningitis belt
populations (Table 1; see also Table S1 in the supplemental material). The WHO Collaborating Centre in
Marseille contributed 20 of these isolates. Isolates were selected first to maximize the temporal and
geographic diversity of the data set and second to focus on three notable epidemics: Saudi Arabia 2000,
Burkina Faso 2002, and Burkina Faso 2012. Isolates from Burkina Faso were identified with the name of
the National Reference Laboratory that provided the isolate, when available. These were Centre Hos-
pitalier Universitaire Pédiatrique-Charles de Gaulle (CHUP-CDG), Centre Hospitalier Universitaire Yalgado
de Ouagadougou (CHU-YO), Centre Hospitalier Universitaire Sanou Souro (CHU-SS), and Centre Muraz.
The serogroup phenotype was confirmed using slide agglutination (28).
Genome sequencing. Pacific Biosciences (PacBio) RSII sequencing was completed for 48 isolates,
using P4-C2 sequencing chemistry. Sequences were assembled using PacBio’s Hierarchical Genome
Assembly Process version 3 (29), where 30 Mb of the longest corrected reads was used for the initial
assembly (see Table S1 in the supplemental material for details). Contiguous sequence (“contig”)
circularity was evaluated by identifying repeats at the ends of the single contig, removing the repeat
from one end, transferring the sequence from the 3= to the 5= end, and assessing whether the manual
join point was supported by remapped reads.
An additional 44 isolates were sequenced on an Illumina HiSeq2500 (or MiSeq) instrument to
examine the bacterial diversity during epidemics. Illumina sequencing libraries were prepared from
extracted DNA by first shearing it to 600 bp using a Covaris LE220 focused ultrasonicator (Covaris, Inc.,
Woburn, MA). The sheared DNA was processed with the NEBNext ultra DNA library preparation kit
following the manufacturer’s protocol (New England Biolabs, Ipswich, MA), using dual barcoding indices.
These libraries were paired end sequenced, using TruSeq rapid SBS (sequencing by synthesis) chemistry,
with either 100 bp or 250 bp at each end (see Table S1 in the supplemental material). Base calling and
demultiplexing were completed with Casava (version 1.8.2). Reads were filtered to have an expected
error rate of 1% (Qual  20) and assembled by SPAdes (version 3.5) (30), discarding small contigs
(300 bp) or those with low coverage (10).
Genome alignment and phylogenetics. The published genome sequence of NM3683 was used
both as a reference for the sequence alignment and as an outgroup to root the phylogeny of CC11. This
isolate was collected in Canada in 1970 and previously shown to be an outgroup to the extant CC11 N.
meningitidis serogroup W population (20). To identify high-quality single-nucleotide polymorphisms
(hqSNPs) for phylogenetic analysis, PacBio assemblies and Illumina read sets were simultaneously aligned
to the reference genome using Lyve-Set 1.0 (31). SNPs less than 3 bp apart were excluded, as were any
base positions with ambiguous characters. The final alignment covered 90.2% of the reference genome
and contained 7,384 variable positions and 1,975,429 invariant positions (see Table S2 in the supple-
mental material). RAxML 8.1.17 (32) was used to generate a phylogeny, using the GTRGAMMAX model
with the Stamatakis ascertainment bias correction and 100 bootstraps. Extended majority rule trees
constructed from replicate bootstrap sets differed by 5% weighted Robinson-Foulds distance (33). To
identify regions with many mutations, all 41 complete genomes were aligned with progressiveMauve
(34), using a hidden Markov model (HMM) identity of 95%, identifying 16,419 SNPs in the core genome
alignment (i.e., where all genomes contained a base). A progressiveMauve (34) alignment of the 9 CC175
single-contig genomes identified 3,026 SNPs in the core genome alignment. ClonalFrameML (35) was
used to account for recombination in a phylogeny constructed from these alignments of single-contig
genomes (see Fig. S1 and S2 in the supplemental material). Custom scripts for evaluation of sequence
data and phylogenies used BioPython (36).
MLST alleles were identified by BLAST searches of PubMLST allele lists against the assembled
genomes (37). Other genes were identified based on the PubMLST annotation of NM3683 where
available and, where it was not available, based on the Fam18 NeMeSys (38) annotation, which was
transferred to NM3683 by using Rapid Annotation Transfer Tool (RATT) (39). Discriminatory SNPs are
those for which variants correspond to monophyletic groups of isolates, distinguishing the specified
clade. Homoplasic SNPs are those for which variants are found in polyphyletic groups of isolates.
Accession number(s). The genomic data are available in the GenBank database under BioProject
accession number PRJNA319252, and individual accession numbers are listed in Table S1 in the
supplemental material.
Meningococcus W Phylogenetics in the Meningitis Belt
Volume 1 Issue 6 e00201-16 msphere.asm.org 9
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://dx.doi.org/10.1128/
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